Ronald Barliant - 31 Dec 2021 Form 4 Insider Report for HUMANIGEN, INC

Role
Director
Signature
/s/ Cameron Durrant, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
+$11,823
Form type
4
Filing time
04 Jan 2022, 17:20:47 UTC
Next filing
29 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $11,823 +4,163 $2.84 4,163 31 Dec 2021 Common Stock 4,163 $3.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted to Mr. Barliant in lieu of $11,831 of cash compensation otherwise payable to Mr. Barliant in respect of his services as a director during the fourth quarter of 2021.